Elite Pharmaceuticals, Inc.

Description:
Elite Pharmaceuticals is the holding company for Elite Laboratories, a drug research and development (R&D) company working on controlled-release pharmaceutical products. The company intends to develop less-expensive, generic versions of existing controlled-release drugs that are nearing the end of their exclusivity period. The company's six products, all of which are in various stages of testing, include angina and hypertension therapies, a nonsteroidal analgesic drug, and a drug to lower blood glucose by stimulating insulin from the pancreas. Elite Laboratories also provides contract R&D sponsored by other pharmaceuticals companies.

Address:                230 W. Passaic St.
                        Maywood, NJ 07606
Phone:                  201-845-6611
Fax:                    201-845-0707

CEO:                    Atul M. Mehta
CFO:                    Atul M. Mehta
HR:                     Atul M. Mehta

Fiscal Year End:        March 
1997 Sales ($ mil.):    0.3
1-Yr. Sales Change:     120.0%
1997 Income ($ mil.):   (0.3)
Employees:              8

Company type:           Private
Filing date:            January 30, 1998
Expected IPO date:      TBA

Shares offered (mil.):  7.45

Proposed Symbol:        ELIP
Proposed Exchange:      Nasdaq (SC)

Additional Sources of Free Information on Elite Pharmaceuticals:

EDGAR Online IPO SEC filings (Real-time)		EDGAR Online IPO SEC filings*** (24-hour delayed)
infoSeek Guide Web Search		Latest News from News Alert
Available to Hoover's Online subscribers.

Need mailing lists? Order your copy of Hoover's Company Capsules on CD-ROM today!